A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is
Concurrent Sessions S11 compared to that of HepG2 or SNU475 with the GA or AA genotype. Conclusions: Our findings suggested that the EGF 61AA genotype may lower HCC risk compared with GG and GA genotypes, and have lower level of EGF protein. In addition, block EGF signaling transduction via gefitinib can slowdown the proliferations of some HCC cell lines.doi:10.1016/s1201-9712(09)60033-3 fatcat:5mdhc6n4c5hvlpkivnctacipua